Life Science REIT PLC (LABS) — Capital Reinvestment Ratio
Life Science REIT PLC (LABS) has a Capital Reinvestment Ratio of 6.06x as of June 2025, meaning it reinvests 6% of its operating cash flow (GBX958.00K) in capital expenditures (GBX5.81 Million). Check Life Science REIT PLC tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Life Science REIT PLC Capital Reinvestment Ratio (2021–2024)
This chart tracks Life Science REIT PLC's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see Life Science REIT PLC (LABS) cash flow conversion.
Annual Capital Reinvestment Ratio for Life Science REIT PLC (2021–2024)
Year-by-year Capital Reinvestment Ratio for Life Science REIT PLC from 2021 to 2024. See LABS FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.49x | GBX12.92 Million | GBX19.28 Million | ▼ -52.7% |
| 2023 | 3.16x | GBX7.62 Million | GBX24.03 Million | ▲ +46.1% |
| 2021 | 2.16x | GBX3.54 Million | GBX7.64 Million | — |